Form D · Other
CytoVeris Inc
Farmington, CT · CIK 0001755494
Offering snapshot reported Nov 3, 2021 · SEC filing
- Reported sold
- $3.4M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 28, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 3, 2021 | Initial | $3,400,000 | No comparison | 1 | SEC filing |
| Apr 27, 2020 | Initial | $3,725,008 | No comparison | 5 | SEC filing |
| Oct 10, 2018 | Initial | $2,850,006 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-419661
Convertible Promissory Notes
Source: Form D, filed Nov 3, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Patrick M. Curry | Executive |
| F. Kevin Didden | Director |
| Scott Flora | Director |
| Michael Grillo | Director |
| Alan D Kersey | Director, Executive |
| Patrick O'neill | Director |
| Michael Sapack | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
400 Farmington Avenue
Farmington, CT, 06032
Farmington, CT, 06032